Principipal Investigators in the consortium

P09: HERBERG, Friedrich & ZIMMERMANN, Bastian (Kassel, GERMANY)
Biaffin GmbH & Co KG

Friedrich W. Herberg is full Professor for Biochemistry at Kassel University since 2002 and co-founder and scientific advisor of the company Biaffin. He studied biology and theology at the Ruhr-University Bochum and got his PhD at the Institute for Physiological Chemistry, Medical School Bochum. From 1990-1994 he worked first as a postdoctoral researcher and later as research associate at the University of California in San Diego on structure/function relations of protein kinases. After returning to Germany he finished his habilitation in 1999. His main research topics are intracellular signal transduction with cAMP-dependent protein kinase as a model system, biomolecular interaction analysis and proteome research.

Bastian Zimmermann is the managing director of the company Biaffin since 2002. He got his diploma in Chemistry at the Department of Biochemistry in Bochum and finished his PhD in 1999 at the Department of Physiological Chemistry, Medical Faculty of the Ruhr-University Bochum. In 1999 he received a grant from the funding program for technology transfer and entrepreneurship and founded the company Biaffin GmbH & Co KG in 2001 together with Professor Herberg. Email contact

The SME partner in the consortium Biaffin is specialising in biomolecular interaction analysis (BIA) using modern real-time biosensors and in the application of BIA technology for customers from the pharmaceutical, biotechnological and diagnostic industry. Biaffin has acquired long experience and expert knowledge in the application of biosensors based on surface plasmon resonance (SPR) and is known to be a reliable partner for the performance of biomolecular interaction analyses and functional assays. The range of services offered also includes the performance of phosphorylation assays and assay development for medium to high throughput functional in vitro assays. Biaffin´s products are bioluminescent assays, recombinant proteins (protein kinases), inhibitors of protein kinases as well as a novel fusion tag technology for combining rapid purification of recombinant proteins with capturing on surfaces for subsequent interaction assays.